MetaCap

Artelo Biosciences (ARTL) vs Clearmind Medicine (CMND)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Clearmind Medicine is the larger company by market cap ($1.3 million vs $1.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARTL-59.24%CMND-60.15%
+3%-30%-63%
Oct 7, 20261 yearNov 20, 2026
ARTL-57.36%CMND-60.03%
+3%-30%-63%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARTL versus CMND key metrics
MetricARTLCMND
Share price$1.39$2.63
Market cap$1.30M$1.33M
1-day change-4.14%-17.68%
EPS (TTM)$-20.56$-461.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-12.88M$-3.86M
52-week high$179.19$649.60
52-week low$1.30$2.63
Distance from 52-week high-99.22%-99.60%
Average volume476.69K55.57K
Shares outstanding937.18K507.40K
Employees7—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Artelo Biosciences

ARTL stock →

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications.

Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees

About Clearmind Medicine

CMND stock →

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.

Health Care · Biotechnology: Pharmaceutical Preparations

ARTL vs CMND FAQ

Which is bigger, Artelo Biosciences or Clearmind Medicine?

Clearmind Medicine (CMND) is larger, with a market capitalization of $1.33M compared with $1.30M for Artelo Biosciences (ARTL).

Are Artelo Biosciences and Clearmind Medicine in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons